Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
about
Amyloid-associated depression: a prodromal depression of Alzheimer disease?Biological markers of amyloid beta-related mechanisms in Alzheimer's diseaseA systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's diseaseBlood-Based Proteomic Biomarkers of Alzheimer's Disease PathologyCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseMild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's diseaseLongitudinal plasma amyloid beta in Alzheimer's disease clinical trials.Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shiftCharacterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology.Biomarkers for cognitive impairment and dementia in elderly people.Reversal of fragile X phenotypes by manipulation of AβPP/Aβ levels in Fmr1KO miceUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Efavirenz promotes β-secretase expression and increased Aβ1-40,42 via oxidative stress and reduced microglial phagocytosis: implications for HIV associated neurocognitive disorders (HAND).Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's diseaseMitochondrial DNA sequence associations with dementia and amyloid-β in elderly African AmericansMultimodal techniques for diagnosis and prognosis of Alzheimer's diseasePlasma beta-amyloid and duration of Alzheimer's disease in adults with Down syndrome.Circulating biomarkers that predict incident dementia.Blood-based biomarkers of Alzheimer's disease: challenging but feasibleTargeting Abeta and tau in Alzheimer's disease, an early interim reportDepression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.Plasma Abeta42 and Abeta40 as markers of cognitive change in follow-up: a prospective, longitudinal, population-based cohort study.Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions.Plasma ß-amyloid and cognitive decline.Biomarkers of Alzheimer's disease: from central nervous system to periphery?Amyloid β levels in human red blood cellsBrain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta.A serum protein-based algorithm for the detection of Alzheimer diseaseComparison of conventional ELISA with electrochemiluminescence technology for detection of amyloid-β in plasmaLong-term low-level arsenic exposure is associated with poorer neuropsychological functioning: a Project FRONTIER study.Circulating miRNA biomarkers for Alzheimer's diseaseAssociation of plasma beta-amyloid level and cognitive reserve with subsequent cognitive declineNon-linear relationships of cerebrospinal fluid biomarker levels with cognitive function: an observational study.Biomarkers of the dementia.Feasibility of Predicting MCI/AD Using Neuropsychological Tests and Serum β-AmyloidIdentification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment.Relation between insulin, insulin-related factors, and plasma amyloid beta peptide levels at midlife in a population-based study.
P2860
Q22253023-1EF454C5-6C5F-4A1A-958D-227F44CF643DQ24622136-7A05C9A5-9789-48C9-9138-F1E3C2AC24FFQ26771808-710CC36C-5222-4EAE-A8B9-2F0594DC814DQ26774743-93AE3271-7930-45A5-8764-4F80DA1A6D13Q27023758-B87A1320-C74B-469B-82EB-9AC63F0A754BQ27027319-6946F856-4BE7-41F1-BBED-0D5413B5CF77Q27310276-14FC46C0-9122-45EC-8093-A2C37AF62EB4Q28582464-B030F027-A9EF-4548-92B0-5D9C25A092C6Q30315907-BBAB14F0-6B4A-42C9-AC91-0AD7FC4D038FQ30370745-79AA38C7-8E85-4179-B21D-07AE0DF07342Q30473360-4436CDD9-467E-49C2-9C1B-2D0C8DA9CDEAQ30845482-27CB5C72-9C0D-42AB-8341-03D7237BA7F7Q31159582-2FF0DC19-7B8E-4838-8271-29715504C440Q33591314-D5C1651F-D5AF-4532-942D-49F82C6D7510Q33603868-4AA6A1FE-496B-4D64-A766-E64A219DBE1CQ33607535-23317A6F-154E-4CF1-9D65-1D768C18FDA9Q33609644-A1997265-C5B1-47A4-9678-75A34C47E061Q33752058-64FBB931-F94A-42A1-80A6-3453323ACDDEQ33824444-5794FE3B-64A8-42BA-9108-AF5D68DFDB65Q33829008-8A07BC07-14CA-493D-85DB-D6EA39EBBF5AQ34056793-F463C518-5F91-40C0-B2E2-87296DD5AC3AQ34292024-F8D1C8CF-1CE2-4DED-8621-081CD5C6FF68Q34318022-D85E3FDA-DDB8-429A-BC8E-3161D3526F30Q34424794-3A8BF355-89B6-482C-9EE9-E2E33DFE7139Q34442605-DEAF5398-6E38-487E-96DB-F3267C9BC3EFQ34482602-3886162D-277A-4F59-88EA-BAC95A1110E6Q34482760-E006866B-AE8F-46D7-87DA-CCED7011D6C0Q34721090-0D312316-6AD6-41F6-BFB7-20C7D55B95CCQ34755504-F54C5A35-A226-41E7-8A6B-C98B8CF7F232Q34786869-4611ADA0-15C1-46E1-ADC7-CAD202AB6767Q34874674-D36CF018-91E6-45C2-8EE1-19D0E2F9B625Q34904013-B3B03516-AC6F-470C-AEC2-84B04AC3EAA0Q35024621-D3948AB2-531C-4810-A837-A27BDD439CF8Q35029099-977DE8EF-3849-4263-9610-F33404C937B2Q35030049-649F61AA-C881-489F-B19F-B1E0CF591BB9Q35030392-05C04BCC-B46E-45C3-8103-9795137F49F2Q35085348-BA4ADCA7-0F33-466C-9E60-2A026A519C25Q35092684-A4704AA0-4CED-44BD-9851-80318D079DBDQ35117068-93A6FF02-9F82-400F-AB46-427EC6FDA3C1Q35118684-BB8E5918-FF88-4F39-935E-7E07BA1AEEC2
P2860
Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Association of low plasma Abet ...... airment and Alzheimer disease.
@en
Association of low plasma Abet ...... airment and Alzheimer disease.
@nl
type
label
Association of low plasma Abet ...... airment and Alzheimer disease.
@en
Association of low plasma Abet ...... airment and Alzheimer disease.
@nl
prefLabel
Association of low plasma Abet ...... airment and Alzheimer disease.
@en
Association of low plasma Abet ...... airment and Alzheimer disease.
@nl
P2093
P1433
P1476
Association of low plasma Abet ...... airment and Alzheimer disease.
@en
P2093
Bradley F Boeve
John Lucas
Julia E Crook
Linda H Younkin
Neill R Graff-Radford
Robert J Ivnik
Ronald C Petersen
Steven G Younkin
P304
P356
10.1001/ARCHNEUR.64.3.354
P577
2007-03-01T00:00:00Z